Publication | Open Access
Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates
26
Citations
30
References
2021
Year
NCT03029598.
| Year | Citations | |
|---|---|---|
Page 1
Page 1